Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
The deal has clear gains for both sides, but AstraZeneca's shares slid 6% after news of the UK firm's biggest purchase ever.
Full Article
Alexion Pharmaceuticals soars 35% after AstraZeneca agrees to $39 billion takeover
Business Insider
0 shares
1 views
You might like
Related news coverage
AstraZeneca stock price falls sharply on a $39 billion bill to buy Alexion
Invezz
Investors don’t seem impressed with AstraZeneca’s (LON: AZN) latest deal, which is also the biggest deal in the company’s..
-
Alexion, Pluralsight rise; SolarWinds, Virgin Galactic fall
SeattlePI.com
-
News24.com | WATCH | AstraZeneca shares dip after $39 billion Alexion deal
News24
-
The Alexion Takeover Is a Major Expansion for AstraZeneca. Why the Stock Is Down 7%
Upworthy
-
Stock Alert: Alexion Pharmaceuticals Jumps 30% On AstraZeneca Takeover
RTTNews
Advertisement
More coverage
AstraZeneca to acquire Alexion Pharmaceuticals for £29.50 billion
Invezz
AstraZeneca plc (LON: AZN) said on Saturday that it will buy Alexion Pharmaceuticals (NASDAQ: ALXN) for £29.50 billion. The..
-
AstraZeneca stock tumbles as Alexion shares soar after companies agree on takeover deal
Upworthy
-
AstraZeneca to Buy Alexion Pharmaceuticals for $39 Billion. What to Know
Upworthy
-
UK's Astrazeneca buying US Biotech firm Alexion for 39 Billion dollars to expand in immunology
Mid-Day
-
AstraZeneca Agrees To Buy Alexion Pharma In $39 Bln Cash And Stock Deal
RTTNews